Navigation Links
Imaging Diagnostic Systems Exhibits at Major Middle East Health Conference
Date:1/29/2008

CTLM Technology to be Highlighted at Molecular Imaging Conference

FORT LAUDERDALE, Fla., Jan. 29 /PRNewswire-FirstCall/ -- Imaging Diagnostic Systems, Inc., (OTC Bulletin Board: IMDS) a pioneer in laser optical breast imaging, is exhibiting at Arab Health 2008, January 28 - 31, 2008, in Dubai, United Arab Emirates. The company is located at stand CD89.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGO )

CTLM technology was featured during the Molecular Imaging Conference, one of 17 conferences on specialized areas featured at Arab Health. Professor Eric Milne detailed the principals of imaging the breast with CTLM in his lecture, "Optical Imaging: Computed Tomographic Laser Mammography of the Breast." Observations from one of the Company's Luminary Partner sites were also presented. Professor Paolo Belli from Catholic University, Rome, Italy, discussed his experiences with CTLM in his talk, "Clinical Experience with Computed Tomography Laser Mammography Breast Scanning System."

"The Molecular Imaging Conference at Arab Health 2008 illustrates dramatically how the most advanced technologies have been rapidly disseminated throughout the world. Heavy emphasis is being placed on the need to image function rather than form, which is where CT Laser Mammography excels," explained Professor Milne. "As part of the Molecular Imaging and PET/CT conference, I presented the methodology and clinical results of CTLM, obtained from 11 of our clinical centers throughout the world. I demonstrated how laser imaging can achieve the same three-dimensional functional images as PET, but without the need for cyclotrons, radioactive injectates, or physicists at a fraction of the cost and time needed for imaging."

More than 50,000 medical professionals are expected to attend Arab Health, the world's largest multi-track healthcare Congress.

About Imaging Diagnostic Systems, Inc.

Imaging Diagnostic Systems, Inc. has developed a revolutionary new imaging device to aid in the detection and management of breast cancer. The CTLM(R) system is a breast imaging system that utilizes patented continuous wave laser technology and computer algorithms to create 3-D images of the breast. The procedure is non-invasive, painless, and does not expose the patient to ionizing radiation or painful breast compression. CT Laser Mammography (CTLM(R)) is designed to be used in conjunction with mammography. It reveals information about blood distribution in the breast and may visualize the process of angiogenesis, which usually accompanies tumor growth.

The FDA has determined that the Company's clinical study is a non- significant risk (NSR) investigational device study under 812.3(m) of the investigational device exemptions (IDE) regulation (21 CFR 812). The CTLM system is limited by United States Federal Law to investigational use only in the United States.

For more information, visit our website: http://www.imds.com

As contemplated by the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this news release may contain forward-looking statements pertaining to future, anticipated, or projected plans, performances and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimates or predictions of future results or events and there can be no assurance that actual results or events will not materially differ from expectations. Further information on potential factors that could affect Imaging Diagnostic Systems, Inc., is included in the Company's filings with the Securities and Exchange Commission. We expressly disclaim any intent or obligation to update any forward-looking statements.

Investor Relations:

Rick Lutz

(404) 261-1196

lcgroup@mindspring.com

Media Contact:

Elizabeth Kelly

(954) 581-9800

kelly@imds.com


'/>"/>
SOURCE Imaging Diagnostic Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Nikon Instruments New NIS-Elements C Delivers Comprehensive Confocal and Widefield Imaging Capabilities in Single Unifying Software Platform
2. Three Palm Software Receives FDA 510(k) Clearance for Its WorkstationOne(TM) Breast Imaging Workstation
3. Imaging Diagnostic Systems CEO Announces Retirement
4. NIST imaging system maps nanomechanical properties
5. Odyssey Thera Granted U.S. Patent for Animal Imaging
6. CRi Announces Nuance 2, the Next-Generation Multispectral Imaging System for Brightfield and Fluorescent-Based Microscopy
7. US Patent and Trademark Office Allows CRis Patent Application for Spectral Imaging of Deep Tissue
8. CRi Announces Maestro 2, the Next Generation in Vivo Optical Imaging Systems
9. Rapid Quantification of Osteoarthritis With a Novel, Office-Based, High-Resolution Digital Imaging Device
10. Delivering Molecular Imaging Solutions Across Clinical Specialties: Siemens Showcases New Technologies at RSNA 2007
11. New Optical Breast Cancer Imaging Technology Garners Cover Story in National Radiology Magazine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... Fluxion Biosciences announced today that Genetracer Biotech ... appointed as a Certified Service Provider for Fluxion,s IsoFlux ... used in Genetracer Biotech,s novel liquid biopsy workflows for ... with plans to move to other cancers as additional ... System to isolate, recover, and analyze CTCs (circulating tumor ...
(Date:2/25/2017)... New York (PRWEB) , ... February 25, 2017 ... ... partnership with Verified Clinical Trials in an ongoing effort to create ... of treatment, advocacy, and pharmaceutical research with emphasis on consumers and patients’ mental ...
(Date:2/24/2017)... KNOXVILLE, Tenn. , Feb. 24, 2017 /PRNewswire/ ... ) ("Provectus" or the "Company"), a clinical-stage oncology ... information regarding the deadline to participate in its ... million units, consisting of shares of common stock ... stockholders and holders of listed warrants. ...
(Date:2/24/2017)... HONG KONG, Feb. 24, 2017 China Cord Blood ... "Company"), China,s leading provider of cord blood collection, laboratory ... services, today announced its unaudited financial results for the ... 2017 ended December 31, 2016. Third Quarter ... the third quarter of fiscal 2017 increased by 18.6% ...
Breaking Biology Technology:
(Date:2/16/2017)...  Genos, a community for personal genetic discovery ... Laboratory Accreditation from the College of American Pathologists ... that meet stringent requirements around quality, accuracy and ... "Genos is committed to maintaining the highest ... to be receiving CAP accreditation," said Jill ...
(Date:2/9/2017)... LONDON , Feb. 9, 2017 The ... in-depth analysis of the biomass boiler market globally in ... sales of biomass boilers. The market for biomass boilers ... product type, end-user, application, and country/region. The market based ... agriculture & forest residues, biogas & energy crops, urban ...
(Date:2/8/2017)... -- Report Highlights The global biosurgery market ... in 2016 at a compound annual growth rate (CAGR) ... - An overview of the global market for biosurgery. ... 2015 and 2016, and projections of compound annual growth ... on the basis of product type, source, application, and ...
Breaking Biology News(10 mins):